The founder, Chief Scientific Officer and member of SBS Board of Directors, Mohi Rezvani is the
former director of the University of Oxford’s Research Institute at Churchill Hospital, Oxford. Mohi
started his career in biology by studying the mechanisms of development and the treatment of
radiation-induced normal tissue injuries in order to ameliorate radiation lesions caused by accidental
exposure to ionising radiation or as side effects of radiotherapy of cancer. He investigated the
potential and efficacy of a number of pharmaceuticals, plant extracts and stem cells as therapeutics.
His main interest is development of stem cell based treatments particularly by utilisation of the
paracrine effect of stem cells and sub-cellular substances such as extracellular vesicles.
Mohi
is a fellow of the Royal Society of Medicine (RSM) and a fellow of the Royal Society of Biology (RSB).
He is the former Chairman of the UK Radiation Research Society and the former President of European
Radiation Research Society.
GMP Expert | Pharmaceutical Executive | Quality & Compliance Leader
A results-driven pharmaceutical executive with extensive experience in GMP/GDP-regulated environments, specializing in advanced therapies, biologics, and pharmaceutical manufacturing. With a strong background in global quality assurance, regulatory compliance, and strategic management, he ensures full adherence to international regulatory standards. His expertise includes leading the life cycle management of global GxP quality processes, optimizing operations, and driving continuous improvement. He is committed to enhancing efficiency, maintaining compliance, and fostering innovation in pharmaceutical manufacturing.
Medical director, SwissBioscience – Schlieren, Switzerland
Dr. Ranieri Mazzei is a renowned expert in plastic and reconstructive surgery, specializing in the clinical application of adipose-derived stem cells (ADSCs) for aesthetic enhancement, body symmetry correction, and post-trauma reconstruction. As the Medical director of SwissBioscience, he leads pioneering research in stem cell-based regenerative therapies, revolutionizing the fields of plastic surgery, anti-aging medicine, and tissue regeneration.
With an extensive background in stem cell biology and translational medicine, Dr. Mazzei has developed innovative protocols for using ADSCs in reconstructive and aesthetic procedures. His work focuses on:
- Plastic & Reconstructive Surgery: Utilizing stem cells from fat tissue to restore volume, correct asymmetries, and improve skin texture in facial and body procedures.
- Post-Trauma & Scar Healing: Enhancing wound healing and minimizing scarring after injuries, burns, or surgical procedures.
- Anti-Aging & Regenerative Aesthetics: Harnessing the regenerative power of stem cells to rejuvenate the skin, improve elasticity, and restore youthful contours.
Dr. Mazzei is actively involved in clinical research and international collaborations, pushing the boundaries of regenerative medicine in plastic surgery. His mission is to develop safer, more effective, and minimally invasive solutions for patients seeking both functional reconstruction and aesthetic refinement.
Head of Quality Control
Dr. Dilara Gürsoy is the Head of Quality Control at SwissBioscience, bringing extensive expertise in molecular and cancer biology. She holds a PhD in Cancer Biology from the University of Zurich, an MSc in Cell Biology from ETH Zurich, and a BSc in Molecular Biology and Genetics from Boğaziçi University. With a strong background in scientific research, quality management, and regulatory compliance, she plays a pivotal role in ensuring the highest standards in production processes.
In her role, Dr. Gürsoy oversees quality control strategies, ensuring that all laboratory and manufacturing processes adhere to Good Manufacturing Practice (GMP) and other industry regulations. She is responsible for the validation of analytical methods, risk assessment, and continuous process improvements to maintain the integrity, reliability, and reproducibility of production outcomes.
Her expertise in molecular and cell-based analytical techniques enables her to implement advanced quality control measures, ensuring the purity, potency, and consistency of hADSCs. She collaborates closely with production teams and regulatory authorities to drive excellence in quality assurance, contributing to SwissBioscience’s commitment to innovation and patient safety.
With a meticulous and detail-oriented approach, Dr. Gürsoy ensures that every product meets the highest safety and efficacy standards, supporting the company’s mission to advance cutting-edge regenerative medicine solutions through rigorous quality control and scientific excellence.
Head of Production
Dr. Niran Maharjan holds a PhD in Neuroscience from the University of Bern and has extensive postdoctoral research experience at EPFL (École Polytechnique Fédérale de Lausanne) and the University Hospital Bern. With over a decade of expertise in primary cell cultures and stem cell research, he has played a pivotal role in advancing neurodegenerative disease models, aiming to uncover the fundamental mechanisms that drive these conditions.
His research background includes the development and optimization of in vitro and in vivo models to study neurological disorders, focusing on cellular dysfunction, neuroinflammation, and regenerative therapies. His expertise in stem cell biology has positioned him at the forefront of translational research, bridging the gap between fundamental science and clinical applications.
As the Head of Production at SwissBioscience, Dr. Maharjan is responsible for overseeing the large-scale production of human adipose-derived stem cells (hADSCs) from lipoaspirates. He ensures that all processes adhere to Good Manufacturing Practice (GMP) standards, maintaining the highest levels of quality, safety, and regulatory compliance. His leadership ensures the consistency and reliability of stem cell products, supporting their application in regenerative medicine, plastic surgery, and therapeutic development.
Dr. Maharjan’s commitment to scientific innovation, precision, and quality assurance drives SwissBioscience’s mission to deliver cutting-edge stem cell solutions for medical advancements.
Deputy Head of Production
Dr. Chloé Turpin is an accomplished scientist with a strong academic background in biochemistry and molecular biology. She holds a Bachelor’s degree in Biochemistry, a Master’s in Life Sciences, and a PhD in Cellular and Molecular Biology, equipping her with extensive expertise in molecular biology, biochemistry, and cell-based analytical techniques.
As the Deputy Head of Production at SwissBioscience, Dr. Turpin plays a critical role in ensuring the highest standards across research, development, and production. She oversees rigorous testing, validation, and regulatory compliance, ensuring that all processes adhere to Good Manufacturing Practice (GMP) and other industry standards. Her work is essential in guaranteeing the purity, potency, and consistency of human adipose-derived stem cells (hADSCs).
With a meticulous approach to quality assurance and scientific integrity, Dr. Turpin implements advanced analytical methodologies to monitor cell viability and functional efficacy. She collaborates closely with researchers, production teams, and regulatory bodies to uphold SwissBioscience’s reputation for excellence in future stem cell-based therapeutics and regenerative medicine.
Her commitment to precision, compliance, and scientific excellence ensures that every product meets the highest safety and efficacy standards, supporting the company’s mission to advance regenerative medicine through innovative, high-quality stem cell solutions.
QC-QA Specialist
Veronica is a dedicated QC-QA Specialist with a Master’s degree in Medical Biotechnologies and PhD-level expertise in Immunology and Human Genetics. With a strong background in biomedical research and personalized medicine, she plays a crucial role in ensuring the accuracy, reliability, and compliance of scientific findings and product developments. Her expertise spans quality control, quality assurance, and regulatory compliance, helping to drive innovation in the healthcare and biotech industries while maintaining the highest standards of precision and excellence.
QA/QC Specialist and R&D Assistant
Ana Eira is a QA/QC Specialist and R&D Assistant, holding a Master’s in Pharmaceutical Technologies and a Bachelor’s in Biomedical Sciences, both from Coimbra University. She ensures quality standards while supporting research and development.
Production Technician
Eni Sinani is an experienced production technician in the manufacturing of stem cells. Eni holds two master’s degrees: one in Molecular Biology from the University of Tirana, and another in Molecular Biotechnology from Anhalt University of Applied Sciences in Germany. Eni’s academic background is complemented by hands-on experience in genetic analysis, cell culture, biochemistry, and advanced laboratory techniques.
Production Technician
Sara Nafi is an experienced production technician in stem cell manufacturing, holding a Master's degree in Medical and Pharmaceutical Biotechnology. Her academic background is further enhanced by hands-on experience in immunology techniques, including histochemistry, immunofluorescence in both 2D and 3D samples, 3D histology, and ultra-light sheet microscopy.